STAT Plus: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target
GSK
GlaxoSmithKline (GSK), one of the largest pharmaceutical companies in the world, is known for its broad array of respiratory medicines and its vaccine business is an industry giant, distributing 2 million doses a day in more than 150 countries. Some of GSK’s most well-known brand-name products include Advair, Breo, Ellipta, Triumeq, Tivicay and Shingrix.
Latest
4 takeaways from STAT’s story on the development of malaria vaccines
CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines
STAT Plus: ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth
STAT Plus: During the pandemic, were great vaccines bad business? A company-by-company review
STAT Plus: ‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
STAT Plus: Major pharma companies call on their suppliers to reduce carbon footprints
All Coverage
advertisement
